• Mc-Val-Cit-PABC-PNP: Technical Guide for ADC Linker Use

  2026-07-13

  Mc-Val-Cit-PABC-PNP addresses the need for a cathepsin B-cleavable ADC peptide linker in antibody-drug conjugate (ADC) research, enabling controlled payload release via lysosomal cleavage. It is intended for organic solvent-based workflows and should not be used in aqueous, therapeutic, or diagnostic applications.

• SB203580 in p38 MAPK Signaling: Protocols and COPD Insights

  2026-07-12

  SB203580, a potent and selective p38 MAPK inhibitor, empowers researchers to dissect inflammation, neuroprotection, and multidrug resistance mechanisms with precision. This guide bridges foundational protocols with advanced troubleshooting and highlights new disease intersections, including its pivotal role in modeling COPD exacerbation by periodontitis pathogens.

• Cefiderocol’s In Vitro Efficacy Against Resistant Gram-Negat

  2026-07-10

  The referenced study systematically evaluated cefiderocol’s in vitro activity against a large European cohort of Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and newer β-lactam/β-lactamase inhibitor combinations. High cefiderocol susceptibility rates, even among multidrug-resistant strains, highlight its potential role in addressing critical treatment gaps for non-fermenting Gram-negative infections.

• Ceftazidime in Gram-Negative Infection Research: Protocols &

  2026-07-09

  Ceftazidime, a potent third-generation cephalosporin, is a benchmark tool for dissecting Gram-negative resistance mechanisms and modeling multidrug-resistant respiratory infections. Here, we outline advanced workflows, troubleshooting strategies, and leverage the latest transmission dynamics research to maximize assay fidelity and translational impact.

• Ertapenem Sodium Salt: Advanced Workflows for Resistance Res

  2026-07-09

  Ertapenem (sodium salt) empowers researchers to dissect multidrug resistance mechanisms in both Gram-positive and Gram-negative bacteria. This article delivers actionable workflows, troubleshooting strategies, and translational insights—drawing on cutting-edge molecular epidemiology and validated protocols for bench-to-biology impact.

• Bioluminescent Probe Synthesis for Immunoproteasome Activity

  2026-07-08

  This study introduces a selective, bioluminescent probe for the immunoproteasome (iCP), enabling direct monitoring of iCP activity in live-cell and tissue-mimetic assays. By detailing a modular peptide synthesis protocol and demonstrating the probe’s selectivity, the work provides a new tool to dissect iCP function in disease contexts and facilitate drug discovery.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-07-08

  Chen et al. (2025) deliver a detailed molecular epidemiological analysis of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China. Their findings highlight the predominance of blaNDM-1 and the rapid horizontal spread of resistance determinants, providing critical insights for antibacterial research and infection control strategies.

• Meropenem Trihydrate: Carbapenem Antibiotic for Resistance S

  2026-07-07

  Meropenem trihydrate offers unmatched utility for investigating antibiotic resistance and infection mechanisms, with strong solubility and validated workflows that enhance reproducibility. Groundbreaking metabolomics research and advanced LC-MS/MS protocols reveal new biomarkers and detection strategies, positioning APExBIO’s product as a cornerstone for translational microbiology.

• Transmission and Diversity of Carbapenemase Genes in CREC in

  2026-07-07

  This study provides a comprehensive molecular characterization of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China, during the COVID-19 period. The findings reveal high rates of multidrug resistance, predominance of blaNDM-1, and efficient horizontal gene transfer, offering crucial insights for antimicrobial resistance research and infection control modeling.

• Gamithromycin Workflows: Applied Protocols & Troubleshooting

  2026-07-06

  Gamithromycin’s unique pharmacokinetics empower researchers to model veterinary respiratory infections with precision, especially for pathogens like Pasteurella multocida and Haemophilus parasuis. This article delivers actionable protocol enhancements, troubleshooting strategies, and practical insights for maximizing assay reliability and translational relevance.

• Ro 3306: Advanced CDK1 Inhibition for Cell Cycle Checkpoint

  2026-07-06

  Explore how Ro 3306, a selective CDK1 inhibitor, enables precise G2/M cell cycle arrest and innovative DNA repair research. This article uniquely integrates oscillatory mTORC1 insights with practical assay design, setting a new standard for cell cycle studies.

• Gamithromycin: Applied Workflows and PK/PD Optimization in R

  2026-07-05

  Gamithromycin (ML-1709460) stands out as a precision macrolide antibiotic for veterinary respiratory disease research, enabling robust, reproducible inhibition of key pathogens. This article delivers actionable protocols, critical troubleshooting insights, and a translational bridge from the latest PK/PD benchmarks to bench-side experimental design.

• Ceftolozane/Tazobactam: Expanding β-Lactam Options for Resis

  2026-07-04

  Ceftolozane/tazobactam represents a significant advance in β-lactam antibiotic combinations, demonstrating potent activity against multidrug-resistant Gram-negative pathogens, including Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. This review analyzes its pharmacological properties, clinical trial outcomes, and implications for resistance modeling, highlighting both strengths and translational challenges for researchers.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-07-03

  This study systematically characterizes the prevalence, genetic localization, and transmission of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China. The findings reveal a dominant role for plasmid-mediated blaNDM-1 and uncover highly efficient horizontal gene transfer, with significant implications for resistance modeling and infection control strategies.

• Transmission of Carbapenemase Genes in CREC: Insights from G

  2026-07-03

  This study offers a detailed molecular epidemiology of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China. By mapping gene localization, transmission mechanisms, and resistance profiles, the research identifies predominant genetic determinants and transmission dynamics, providing critical data for combating multidrug-resistant Gram-negative infections.

706 records 7/48 page Previous Next First page 上5页 678910 下5页 Last page